Increased toxicity and DNA cross-linking by peptide bound m-L-sarcolysin (Peptichemio) as compared to melphalan and m-L-sarcolysin in human melanoma cell lines

Anticancer Res. 1991 Jan-Feb;11(1):321-4.

Abstract

Alteration of the melphalan molecule by shifting the di(2-choroethyl)aminogroup from the para- to the meta-position of the phenylalanine residue results in m-L-sarcolysin. By covalent conjugation of different amino acids at the amino- and carboxylgroups of this molecule, a mixture of six peptides known as Peptichemio has been synthesized. In a previous investigation we found that Peptichemio was less toxic to human lymphoblasts than m-L-sarcolysin. In contrast, in the present investigation we found that Peptichemio has higher cytotoxic effect than m-L-sarcolysin on two human melanoma cell lines. The higher cytotoxicity was paralleled by a higher induction of DNA cross-links by Peptichemio as compared to m-L-sarcolysin. A comparative analysis of the six peptides on Peptichemio showed differences in cytotoxic effects on a melanoma cell line. One of the six peptides displayed a considerably higher cytotoxicity than peptichemio itself.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Cell Survival / drug effects
  • Cross-Linking Reagents / pharmacology*
  • DNA, Neoplasm / drug effects*
  • Drug Interactions
  • Drug Screening Assays, Antitumor
  • Humans
  • Melanoma
  • Melphalan / analogs & derivatives*
  • Melphalan / pharmacology*
  • Peptichemio / pharmacology*

Substances

  • Cross-Linking Reagents
  • DNA, Neoplasm
  • metamelfalan
  • Peptichemio
  • Melphalan